2023 ETF Series Trust II (The) - GMO U.S. Quality ETF
QLTY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.44B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.44 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.30 |
| Dividend yield | 0.65% |
| Earnings per Share | $- |
| Beta | 0.98 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.34%▼ 76.29% |
|---|---|
| Total Invested | $332.03M▼ 91.40% |
| Investors Holding | 8▼ 151.00% |
About 2023 ETF Series Trust II (The)
CEO: Tracey Keenan
The GMO Ultra-Short Income ETF (GMOC) meticulously builds a low-duration fixed income portfolio, encompassing a variety of high-quality assets. These assets include U.S. Treasuries, Collateralized Loan Obligations (CLOs), and both repurc...